Funding

Pfizer and BioNTech Settle $740M mRNA Patent Dispute with CureVac

Pfizer and BioNTech have reached a substantial $740 million settlement agreement with CureVac to resolve a complex patent dispute involving foundational mRNA technology that underpins

Healthcare Technology

Digital Health Funding Rebounds as AI Solutions Capture Investor Interest

The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but

MedTech

HistoSonics Achieves $2.25B Valuation in Strategic Investor Buyout

HistoSonics has secured a transformative investment that values the innovative medical device company at $2.25 billion, with a consortium led by Johnson & Johnson Development

Funding

Pfizer and BioNTech Settle $740M mRNA Patent Dispute with CureVac

Digital Health Funding Rebounds as AI Solutions Capture Investor Interest

HistoSonics Achieves $2.25B Valuation in Strategic Investor Buyout

Join a Community of 35,000+ Industry Leaders and Innovators

Stay Ahead in Biotech & MedTech Innovations

Join the BioMed Nexus community and get the latest breakthroughs, research updates, and industry insights delivered straight to your inbox.